相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer
Sheng-Mao Wu et al.
CELL BIOLOGY AND TOXICOLOGY (2023)
HDAC2 Facilitates Pancreatic Cancer Metastasis
Lukas Krauss et al.
CANCER RESEARCH (2022)
The ambiguous role of sirtuins in head and neck squamous cell carcinoma
Devaraj Ezhilarasan et al.
ORAL DISEASES (2022)
Hematological Consequences of Valproic Acid in Pediatric Patients: A Sys- tematic Review with a Mechanistic Approach
Bamdad Riahi-Zanjani et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2022)
Metabolic reprogramming and epigenetic modifications on the path to cancer
Linchong Sun et al.
PROTEIN & CELL (2022)
Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC)
Jessica L. S. Zylla et al.
CANCERS (2022)
Class I and II Histone Deacetylase Inhibitor LBH589 Promotes Endocrine Differentiation in Bone Marrow Derived Human Mesenchymal Stem Cells and Suppresses Uncontrolled Proliferation
Christoph Schroeder et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2021)
Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy
Sonali Kumar et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2021)
Oncogenic miRNA-1908 targets HDAC10 and promotes the aggressive phenotype of cervical cancer cell
Dong-Sheng Yu et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2021)
HDAC6 as privileged target in drug discovery: A perspective
Sravani Pulya et al.
PHARMACOLOGICAL RESEARCH (2021)
METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease
Zhaoxia Xu et al.
CELL DEATH & DISEASE (2021)
Hallmarks of cancer-the new testament
Sasi S. Senga et al.
OPEN BIOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness
Lei Bi et al.
CANCER RESEARCH (2021)
Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancer
Zeynep Ozman et al.
MOLECULAR BIOLOGY REPORTS (2021)
Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells
Wen-Bin Yang et al.
CELL DEATH & DISEASE (2021)
Evaluation of a clinical-grade, cryopreserved, ex vivo-expanded stem cell product from cryopreserved primary umbilical cord blood demonstrates multilineage hematopoietic engraftment in mouse xenografts
Christoph Schaniel et al.
CYTOTHERAPY (2021)
First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
Pim B. van der Meer et al.
EPILEPSIA (2021)
Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders
Piyush Gediya et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
Jacob King et al.
METABOLITES (2021)
Repurposing Vorinostat for the Treatment of Disorders Affecting Brain
K. V. Athira et al.
NEUROMOLECULAR MEDICINE (2021)
Targeting BMI-1-mediated epithelial-mesenchymal transition to inhibit colorectal cancer liver metastasis
Zhiyao Xu et al.
ACTA PHARMACEUTICA SINICA B (2021)
Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors
Afua Adjeiwaa Mensah et al.
BLOOD ADVANCES (2021)
The Emerging Role of Epigenetics in Therapeutic Targeting of Cardiomyopathies
Christina Pagiatakis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Evaluation of acetylation and methylation in oral rinse of patients with head and neck cancer history exposed to valproic acid
Ricardo Ribeiro Gama et al.
SCIENTIFIC REPORTS (2021)
Valproic Acid and Breast Cancer: State of the Art in 2021
Anna Wawruszak et al.
CANCERS (2021)
Nonredundant, isoform-specific roles of HDAC1 in glioma stem cells
Costanza Lo Cascio et al.
JCI INSIGHT (2021)
Epigenetics of aging and disease: a brief overview
Christina Pagiatakis et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)
Histone Deacetylase 7 Inhibition in a Murine Model of Gram-Negative Pneumonia-Induced Acute Lung Injury
George Kasotakis et al.
SHOCK (2020)
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
Eros Di Giorgio et al.
NUCLEIC ACIDS RESEARCH (2020)
A short guide to histone deacetylases including recent progress on class II enzymes
Suk-Youl Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Role of Sirtuins in Tumor Angiogenesis
Lincy Edatt et al.
FRONTIERS IN ONCOLOGY (2020)
Oxygen Is the High-Energy Molecule Powering Complex Multicellular Life: Fundamental Corrections to Traditional Bioenergetics
Klaus Schmidt-Rohr
ACS OMEGA (2020)
Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1
Leiming Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Hypoxia-activated pro-drugs of the KDAC inhibitor vorinostat (SAHA)
Ewen D. D. Calder et al.
TETRAHEDRON (2020)
miR-143 promotes angiogenesis and osteoblast differentiation by targeting HDAC7
Renkai Wang et al.
CELL DEATH & DISEASE (2020)
Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2
Namrata Bora-Singhal et al.
SCIENTIFIC REPORTS (2020)
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
Giorgio Milazzo et al.
GENES (2020)
USP38 regulates the stemness and chemoresistance of human colorectal cancer via regulation of HDAC3
Wei Zhan et al.
ONCOGENESIS (2020)
Emerging role of sirtuins in breast cancer metastasis and multidrug resistance: Implication for novel therapeutic strategies targeting sirtuins
Sonam Sinha et al.
PHARMACOLOGICAL RESEARCH (2020)
Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner
Wenzhi Shen et al.
BRITISH JOURNAL OF CANCER (2020)
HDAC10 Regulates Cancer Stem-Like Cell Properties in KRAS-Driven Lung Adenocarcinoma
Yixuan Li et al.
CANCER RESEARCH (2020)
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Flavia Alves Verza et al.
CANCERS (2020)
Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems
Trang T. T. Nguyen et al.
CELLS (2020)
Metabolic Adaptations in Cancer Stem Cells
Umesh Prasad Yadav et al.
FRONTIERS IN ONCOLOGY (2020)
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
Alexandre Perla et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Promoter Hypomethylation and miR-145-5p Downregulation- Mediated HDAC11 Overexpression Promotes Sorafenib Resistance and Metastasis of Hepatocellular Carcinoma Cells
Wenlong Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals
Panpan An et al.
ONCOGENE (2020)
Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer
Wenjing Wang et al.
MOLECULAR CANCER (2020)
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
Lourdes Hontecillas-Prieto et al.
FRONTIERS IN GENETICS (2020)
Combined Inhibition of Specific Sirtuins as a Potential Strategy to Inhibit Melanoma Growth
Chandra K. Singh et al.
FRONTIERS IN ONCOLOGY (2020)
Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
Hirva Mamdani et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer
Xue-ting Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
HDAC11: a rising star in epigenetics
Shan-Shan Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Cancer Statistics, 2020: Report From National Cancer Registry Programme, India
Prashant Mathur et al.
JCO GLOBAL ONCOLOGY (2020)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Hongyi Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer
Zohaib Rana et al.
BIOMEDICINES (2020)
Anticonvulsant valproic acid and other short-chain fatty acids as novel anticancer therapeutics: Possibilities and challenges
Katarzyna Lipska et al.
ACTA PHARMACEUTICA (2020)
Anorectal Cancer in Crohn's Disease Has a Poor Prognosis Due to its Advanced Stage and Aggressive Histological Features: a Systematic Literature Review of Japanese Patients
Takeshi Ueda et al.
JOURNAL OF GASTROINTESTINAL CANCER (2020)
Transcriptional and Epigenomic Regulation of Adipogenesis
Ji-Eun Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Anna Wawruszak et al.
CANCERS (2019)
Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition
Ashley L. Kalinski et al.
JOURNAL OF CELL BIOLOGY (2019)
HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells
Valentina Cutano et al.
MOLECULAR ONCOLOGY (2019)
Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering
Liam Lawlor et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2019)
SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
Vignesh Sundararajan et al.
SCIENTIFIC REPORTS (2019)
Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors
Maria Serena Roca et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The stem cell-associated transcription co-factor, ZNF521, interacts with GLI1 and GLI2 and enhances the activity of the Sonic hedgehog pathway
Stefania Scicchitano et al.
CELL DEATH & DISEASE (2019)
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis
Amal M. El-Naggar et al.
EMBO REPORTS (2019)
MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression
Mohammad-Nazir Menbari et al.
LIFE SCIENCES (2019)
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma
Francesco Marampon et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1
Siyuan Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Adipogenesis and metabolic health
Alexandra L. Ghaben et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Functions and mechanisms of non-histone protein acetylation
Takeo Narita et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma
Shanshan Zhang et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
HDAC9 overexpression confers invasive and angiogenic potential to triple negative breast cancer cells via modulating microRNA-206
Eric Salgado et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
HDAC11 is a regulator of diverse immune functions
Cansu Yanginlar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2018)
HtrA1 as a promising tissue marker in cancer: a meta-analysis
Emma Altobelli et al.
BMC CANCER (2018)
Role of histone deacetylase 1 in distant metastasis of pancreatic ductal cancer
Go Shinke et al.
CANCER SCIENCE (2018)
MiR-2861 Behaves as a Biomarker of Lung Cancer Stem Cells and Regulates the HDAC5-ERK System Genes
Mengya Zhao et al.
CELLULAR REPROGRAMMING (2018)
Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer
Yuqian Yan et al.
EMBO MOLECULAR MEDICINE (2018)
Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities
Baigalmaa Lkhagva et al.
EPIGENETICS (2018)
Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells
Peng-Chan Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients
Won Young Tak et al.
INVESTIGATIONAL NEW DRUGS (2018)
Histone deacetylase 6 in cancer
Ting Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Expression profiles of histone modification genes in gastric cancer progression
Seda Orenay-Boyacioglu et al.
MOLECULAR BIOLOGY REPORTS (2018)
MiR-520b restrains cell growth by targeting HDAC4 in lung cancer
Ke Jin et al.
THORACIC CANCER (2018)
Co-repressor, co-activator and general transcription factor: the many faces of the Sin3 histone deacetylase (HDAC) complex
Grace E. Adams et al.
BIOCHEMICAL JOURNAL (2018)
Epigenetic Targets and their Inhibitors in Cancer Therapy
Le Zhao et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice
Mouad Edderkaoui et al.
GASTROENTEROLOGY (2018)
HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9
Dong-qin Chen et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Functional Analysis of HDAC11 in Plasma Cell Development and Multiple Myeloma Survival
A. G. M. Mostofa et al.
BLOOD (2018)
Broccoli Sprouts Delay Prostate Cancer Formation and Decrease Prostate Cancer Severity with a Concurrent Decrease in HDAC3 Protein Expression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice
Laura M. Beaver et al.
CURRENT DEVELOPMENTS IN NUTRITION (2018)
Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1
M. Hulsurkar et al.
ONCOGENE (2017)
Targeting triple negative breast cancer with histone deacetylase inhibitors
Palma Fedele et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
The adverse effects of valproic acid on visual functions in the treatment of retinitis pigmentosa
Yuksel Totan et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2017)
Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer
Shiyi Yu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
Yubin Lei et al.
MOLECULAR CANCER (2017)
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Jennifer L. Guerriero et al.
NATURE (2017)
HDAC10 promotes angiogenesis in endothelial cells through the PTPN22/ERK axis
Baoyu Duan et al.
ONCOTARGET (2017)
MAP3K4 Controls the Chromatin Modifier HDAC6 during Trophoblast Stem Cell Epithelial-to-Mesenchymal Transition
Robert J. Mobley et al.
CELL REPORTS (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
Christos Damaskos et al.
ANTICANCER RESEARCH (2017)
Sirtuins at the crossroads of stemness, aging, and cancer
Carol O'Callaghan et al.
AGING CELL (2017)
HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis
Hyun-Wook Ryu et al.
CANCER LETTERS (2017)
Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis
Sridhar Murahari et al.
BMC CANCER (2017)
Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells
Claudia Schaefer et al.
CELLULAR SIGNALLING (2017)
Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients
Zhen Lv et al.
MOLECULAR CARCINOGENESIS (2016)
Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy
Terri S. Armstrong et al.
NEURO-ONCOLOGY (2016)
Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability
Min-Wu Chao et al.
ONCOTARGET (2016)
A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease
Lillianne H. Wright et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
The world of protein acetylation
Adrian Drazic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2016)
Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success
John A. Halsall et al.
BIOESSAYS (2016)
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
Swathi Ramakrishnan et al.
BMC CANCER (2016)
Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity
Zhiqiang Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
SnapShot: Exercise Metabolism
Brendan Egan et al.
CELL METABOLISM (2016)
Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells
Sin Y. Choi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
Jiaqi Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
CLASS I HDAC INHIBITION AND P53 ACTIVATION UPREGULATES MASPIN IN HUMAN PROSTATE CANCER
Eswar Shankar et al.
JOURNAL OF UROLOGY (2016)
Cancer stem cell metabolism: a potential target for cancer therapy
Abhijeet Deshmukh et al.
MOLECULAR CANCER (2016)
Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms
Maria Pinkerneil et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition
Raffaele Palmirotta et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Histone Modifications and Cancer
James E. Audia et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms
L. Wang et al.
CELL DEATH & DISEASE (2016)
HDAC10 promotes lung cancer proliferation via AKT phosphorylation
Yiwei Yang et al.
ONCOTARGET (2016)
Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
Marion Lapierre et al.
ONCOTARGET (2016)
Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation
Vidhi Gaur et al.
CELL REPORTS (2016)
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases
Kaustav Das Gupta et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers
Srividya Bhaskara
CELL CYCLE (2015)
Panobinostat for the Treatment of Multiple Myeloma
Jacob P. Laubach et al.
CLINICAL CANCER RESEARCH (2015)
ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
Simone Meidhof et al.
EMBO MOLECULAR MEDICINE (2015)
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma
James S. Wilmott et al.
MODERN PATHOLOGY (2015)
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
K. V. Woan et al.
MOLECULAR ONCOLOGY (2015)
Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation
I. Rettig et al.
CELL DEATH & DISEASE (2015)
Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage
Hyeonseok Ko et al.
ONCOTARGET (2015)
TGF-β1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4
Huiling Wang et al.
PLOS ONE (2015)
The Class I Hdac Inhibitor Mgcd0103 Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Initiating Cells by Upregulating Dickkopf-1 and Non-Canonical Wnt Signaling
Oncotarget (2015)
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells
Ahrum Min et al.
BREAST CANCER RESEARCH (2015)
Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma
Xiao-Wen Liu et al.
AUTOPHAGY (2014)
HDAC3 acts as a negative regulator of angiogenesis
Deokbum Park et al.
BMB REPORTS (2014)
Histone deacetylase 6 activity is critical for the metastasis of Burkitt s lymphoma cells
Ning Ding et al.
CANCER CELL INTERNATIONAL (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
Ji Zhang et al.
MOLECULAR CELL (2014)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
S. S. Roy et al.
ONCOGENE (2014)
Seizure Prognosis in Brain Tumors: New Insights and Evidence-Based Management
Charles J. Vecht et al.
ONCOLOGIST (2014)
Ginsenoside Rg3 Inhibits Melanoma Cell Proliferation through Down-Regulation of Histone Deacetylase 3 (HDAC3) and Increase of p53 Acetylation
Xiu Shan et al.
PLOS ONE (2014)
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma
Joydeep Bhadury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
HDAC8 and STAT3 repress BMF gene activity in colon cancer cells
Y. Kang et al.
CELL DEATH & DISEASE (2014)
Histone Deacetylase 9 Promotes Angiogenesis by Targeting the Antiangiogenic MicroRNA-17-92 Cluster in Endothelial Cells
David Kaluza et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
Berit Maria Mueller et al.
BMC CANCER (2013)
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Mirjana B. Colovic et al.
CURRENT NEUROPHARMACOLOGY (2013)
Inhibition of Class I Histone Deacetylases Unveils a Mitochondrial Signature and Enhances Oxidative Metabolism in Skeletal Muscle and Adipose Tissue
Andrea Galmozzi et al.
DIABETES (2013)
Metabolic and endocrine effects of valproic acid chronic treatment
Vincenzo Belcastro et al.
EPILEPSY RESEARCH (2013)
HDAC11 is a novel drug target in carcinomas
Hedwig E. Deubzer et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Histone Deacetylase (HDAC) 10 Suppresses Cervical Cancer Metastasis through Inhibition of Matrix Metalloproteinase (MMP) 2 and 9 Expression
Chenlin Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Deacetylase-Independent Function of HDAC3 in Transcription and Metabolism Requires Nuclear Receptor Corepressor
Zheng Sun et al.
MOLECULAR CELL (2013)
HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
Claudia Simoes-Pires et al.
MOLECULAR NEURODEGENERATION (2013)
Valproic acid pathway: pharmacokinetics and pharmacodynamics
Yogita Ghodke-Puranik et al.
PHARMACOGENETICS AND GENOMICS (2013)
Development of a histone deacetylase 6 inhibitor and its biological effects
Ju-Hee Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells
X. Chen et al.
CELL DEATH & DISEASE (2013)
The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells
Andrei Turtoi et al.
ANGIOGENESIS (2012)
Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation
Juergen Sonnemann et al.
CANCER BIOLOGY & THERAPY (2012)
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Berkley E. Gryder et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Structural Basis for Sirtuin Activity and Inhibition
Hua Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Warburg Effect Dictates the Mechanism of Butyrate-Mediated Histone Acetylation and Cell Proliferation
Dallas R. Donohoe et al.
MOLECULAR CELL (2012)
Histone deacetylases and cancer
Bruna Barneda-Zahonero et al.
MOLECULAR ONCOLOGY (2012)
A Hormone-Dependent Module Regulating Energy Balance
Biao Wang et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells
Steffen Wedel et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin
David Kaluza et al.
EMBO JOURNAL (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Histone Deacetylase 9 Is a Negative Regulator of Adipogenic Differentiation
Tapan K. Chatterjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Diet-induced Lethality Due to Deletion of the Hdac3 Gene in Heart and Skeletal Muscle
Zheng Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-Myc
Caihua Zhu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Initial steps of metastasis: Cell invasion and endothelial transmigration
Franziska van Zijl et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2011)
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
Melissa M. Singh et al.
NEURO-ONCOLOGY (2011)
Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
Nivea Dias Amoedo et al.
PLOS ONE (2011)
Mammalian Sirtuins: Biological Insights and Disease Relevance
Marcia C. Haigis et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability
Srividya Bhaskara et al.
CANCER CELL (2010)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer
Kyung Hee Lee et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
Shomit Sengupta et al.
MOLECULAR CELL (2010)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Ina Oehme et al.
CLINICAL CANCER RESEARCH (2009)
E-Cadherin Regulates Metastasis of Pancreatic Cancer In Vivo and Is Suppressed by a SNAIL/HDAC1/HDAC2 Repressor Complex
Johannes von Burstin et al.
GASTROENTEROLOGY (2009)
HDAC4 Represses Vascular Endothelial Growth Factor Expression in Chondrosarcoma by Modulating RUNX2 Activity
Xiaojuan Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Histone Deacetylase Inhibitors: Potential in Cancer Therapy
P. A. Marks et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Glucose Metabolism as a Target of Histone Deacetylase Inhibitors
Suzanne E. Wardell et al.
MOLECULAR ENDOCRINOLOGY (2009)
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Carles Canto et al.
NATURE (2009)
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W. Weichert et al.
BRITISH JOURNAL OF CANCER (2008)
Conserved metabolic regulatory functions of sirtuins
Bjoern Schwer et al.
CELL METABOLISM (2008)
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer:: Specific role of class I histone deacetylases in vitro and in vivo
Wilko Weichert et al.
CLINICAL CANCER RESEARCH (2008)
AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5
Sean L. McGee et al.
DIABETES (2008)
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
Sarah K. Knutson et al.
EMBO JOURNAL (2008)
Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo
Siraj Sami et al.
JOURNAL OF BIOCHEMISTRY (2008)
Requirement of HDAC6 for transforming growth factor-β1-induced epithelial-mesenchymal transition
Bin Shan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Maintenance of cardiac energy by histone deacetylase 3 metabolism in mice
Rusty L. Montgomery et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Class I HDAC expression patterns are highly prognostic in human gastric cancer
M. Ebert et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control
Srividya Bhaskara et al.
MOLECULAR CELL (2008)
The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
Michael T. Buckley et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model
Hasan C. Ugur et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma
Rajeev Vibhakar et al.
NEURO-ONCOLOGY (2007)
Energy metabolism in tumor cells
Rafael Moreno-Sanchez et al.
FEBS JOURNAL (2007)
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
S Ropero et al.
NATURE GENETICS (2006)
Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC
XN Li et al.
MOLECULAR CANCER THERAPEUTICS (2005)
The many faces of REST oversee epigenetic programming of neuronal genes
N Ballas et al.
CURRENT OPINION IN NEUROBIOLOGY (2005)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family
L Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling
CF Deroanne et al.
ONCOGENE (2002)
Expression profile of histone deacetylase 1 in gastric cancer tissues
JH Choi et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
MS Kim et al.
NATURE MEDICINE (2001)
分享论文
